Mucosal inflammation and asthma.

[1]  P. Howarth,et al.  Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. , 1994, American journal of respiratory cell and molecular biology.

[2]  P. Howarth,et al.  Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. , 1994, The Journal of clinical investigation.

[3]  P. Howarth,et al.  Induction of nitric oxide synthase in asthma , 1993, The Lancet.

[4]  P. Howarth,et al.  Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. , 1993, Journal of immunology.

[5]  P. Howarth,et al.  Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. , 1993, The European respiratory journal.

[6]  A. Sousa,et al.  Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. , 1993, The American review of respiratory disease.

[7]  T. Haahtela,et al.  Airway mucosal inflammation even in patients with newly diagnosed asthma. , 1993, The American review of respiratory disease.

[8]  S. Durham,et al.  Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. , 1993, American journal of respiratory cell and molecular biology.

[9]  P. Howarth,et al.  Interleukin 4 is localized to and released by human mast cells , 1992, The Journal of experimental medicine.

[10]  J. Virchow,et al.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. , 1992, The American review of respiratory disease.

[11]  P. Howarth,et al.  Early changes in T lymphocytes recovered by bronchoalveolar lavage after local allergen challenge of asthmatic airways. , 1992, The American review of respiratory disease.

[12]  A. Wardlaw,et al.  Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. , 1992, Blood.

[13]  P. Howarth,et al.  Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. , 1992, The American review of respiratory disease.

[14]  J. Bousquet,et al.  Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. , 1992, The American review of respiratory disease.

[15]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[16]  J. Virchow,et al.  Early activation or "priming" of eosinophils in asthma. , 1992, Schweizerische medizinische Wochenschrift.

[17]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[18]  A. Capron,et al.  Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease , 1992, The Journal of experimental medicine.

[19]  W. Busse,et al.  Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. , 1991, The American review of respiratory disease.

[20]  S. Durham,et al.  Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. , 1991, The Journal of allergy and clinical immunology.

[21]  J. Bousquet,et al.  Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. , 1991, The American review of respiratory disease.

[22]  H. Kita,et al.  Materials and Methods Brief Definitive Report Granulocyte/macrophage Colony-stimulating Factor and Interleukin 3 Release from Human Peripheral Blood Eosinophils and Neutrophils , 2022 .

[23]  E. Bleecker,et al.  Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. , 1991, The American review of respiratory disease.

[24]  L. Koenderman,et al.  Modulation and induction of eosinophil chemotaxis by granulocyte- macrophage colony-stimulating factor and interleukin-3 , 1991 .

[25]  H. Counihan,et al.  Eridothelin immunoreactivity of airway epithelium in asthmatic patients , 1991, The Lancet.

[26]  J. Lanchbury,et al.  Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. , 1991, Journal of immunology.

[27]  T. Lee,et al.  Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. , 1991, Journal of immunology.

[28]  P. Howarth,et al.  Airway inflammation and atopic asthma: a comparative bronchoscopic investigation. , 1991, International archives of allergy and applied immunology.

[29]  M. Jordana,et al.  Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). , 1991, American journal of respiratory cell and molecular biology.

[30]  P. Howarth,et al.  Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. , 1991, The American review of respiratory disease.

[31]  S. Durham,et al.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. , 1990, The American review of respiratory disease.

[32]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[33]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[34]  E. Bleecker,et al.  Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. , 1990, The American review of respiratory disease.

[35]  E. Tam,et al.  Degradation of airway neuropeptides by human lung tryptase. , 1990, American journal of respiratory cell and molecular biology.

[36]  J. Pujol,et al.  Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. , 1990, International archives of allergy and applied immunology.

[37]  J. Resau,et al.  Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. , 1989, The American review of respiratory disease.

[38]  D. Wagner,et al.  PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. , 1989, Blood.

[39]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[40]  S. Wenzel,et al.  Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. , 1989, The American review of respiratory disease.

[41]  S. Wenzel,et al.  Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. , 1988, The American review of respiratory disease.

[42]  H. Sluiter,et al.  Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[43]  A. Wardlaw,et al.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[44]  J. Bousquet,et al.  Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. , 1987, The Journal of allergy and clinical immunology.

[45]  T. Casale,et al.  Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. , 1987, The Journal of clinical investigation.

[46]  K. Matsushima,et al.  There is more than one interleukin 1. , 1986, Immunology today.

[47]  N. Johnson,et al.  Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. , 1985, British medical journal.

[48]  E. Goetzl,et al.  Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Capron,et al.  STIMULATION OF ALVEOLAR MACROPHAGES IN ASTHMATIC PATIENTS AFTER LOCAL PROVOCATION TEST , 1983, The Lancet.

[50]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.

[51]  B. Naylor.  The Shedding of the Mucosa of the Bronchial Tree in Asthma , 1962, Thorax.

[52]  M. Dunnill.  THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.

[53]  K. Koessler,et al.  THE PATHOLOGY OF BRONCHIAL ASTHMA , 1922 .